A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis
Multiple sclerosis (MS) is a complex disease of the central nervous system (CNS). The etiology of this multifactorial disease has not been clearly defined. Conventional medical treatment of MS has progressed, but is still based on symptomatic treatment. One of the key factors in the pathogenesis of...
Main Authors: | Elzbieta Dorota Miller, Angela Dziedzic, Joanna Saluk-Bijak, Michal Bijak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/11/7/1528 |
Similar Items
-
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
by: Angela Dziedzic, et al.
Published: (2020-08-01) -
The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
by: Angela Dziedzic, et al.
Published: (2020-03-01) -
Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
by: Joanna Saluk-Bijak, et al.
Published: (2019-02-01) -
The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
by: Angela Dziedzic, et al.
Published: (2021-02-01) -
Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis
by: Angela Dziedzic, et al.
Published: (2020-10-01)